Aigen Investment Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,075	Closed	-$175K	–	682
2025 Q3	$175K	Buy	12,075 +1,413	+13%	+$20.3K	0.03%	695
2025 Q2	$149K	Buy	+10,662	New	+$150K	0.02%	689
2023 Q3	–	Sell	-19,594	Closed	-$578K	–	887
2023 Q2	$578K	Buy	+19,594	New	+$551K	0.09%	313
2023 Q1	–	Sell	-10,751	Closed	-$299K	–	668
2022 Q4	$299K	Buy	+10,751	New	+$320K	0.04%	364
2021 Q3	–	Sell	-3,243	Closed	-$254K	–	522
2021 Q2	$254K	Sell	3,243 -322	-9%	-$19.9K	0.04%	354
2021 Q1	$204K	Buy	+3,565	New	+$239K	0.03%	539
2020 Q4	–	Sell	-12,877	Closed	-$461K	–	831
2020 Q3	$461K	Buy	+12,877	New	+$388K	0.06%	420
2020 Q1	–	Sell	-2,982	Closed	-$52K	–	1326
2019 Q4	$52K	Buy	+2,982	New	+$49.6K	0.01%	801